Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

About this trial

This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these programs among people who inject drugs in prison. The study is being conducted in nine federal prisons, including five women's prisons, where a higher proportion of incarcerated individuals report a history of injection drug use. This study aims to improve PNEP adoption and sustainability by identifying barriers and facilitators and implementing evidence-based strategies to enhance program engagement.

Eligibility criteria

Qualifiers

All people incarcerated at a study site during the intervention period

Disqualifiers

None

Trial design

Treatments tested in this trial

  • NIATx

Treatment groups

548 Participants
are divided into 3 treatment groups

Locations

9
Alberta
Edmonton Institution for WomenT5S 2H9, Edmonton Canada
British Columbia
Fraser Valley Institution for WomenV2S 1A1, Abbotsford British Columbia Canada
Mission InstitutionV2V 4L8, Mission Canada
New Brunswick
Dorchester MediumE4K 2Y9, Dorchester Canada

Sponsors and collaborators

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead sponsor

Yale University

Collaborator

Burnet Institute

Collaborator

Kirby Institute

Collaborator